Products
PRIMARY ANTIBODY
SECONDARY ANTIBODY
PROTEIN & PEPTIDES
BIOCHEMICALS
ASSAY & ELISA KITS
LOADING CONTROL
OTHER REAGENTS
SERUMS
CELL LINE
Contact Us
About Us
Login
Register
|
Forgot Password
Sign In
Forgot your Password?
If you've forgotten your password, enter your e-mail address below and we'll send you instructions on how to securely change your password.
Back
Continue
0
Shopping Cart
Products
Contact Us
About Us
Shopping Cart
Loading....
Login Account
Sign In
Register
Register
|
Forgot Password
Sign In
Forgot your Password?
If you've forgotten your password, enter your e-mail address below and we'll send you instructions on how to securely change your password.
Back
Continue
0
Shopping Cart
Home
BioChemicals
AG-490
tcsc0108
AG-490
Order Now
AVAILABLE SIZES
10mg
50mg
100mg
200mg
$
151.00
Add to Cart
ORDERING INFORMATION
International
TAICLONE BIOTECH CORP.
order@taiclone.com
+886-2-2735-9682
+886-2-2735-9807
Data sheet
Download PDF Datasheet
Technical Inquries
Submit Review
Submit Review
Please choose your application, enter the information requested below. * Marked fields are mandatory.
Full Name
Email
Contact Number
Application
Please Select..
Western blot (WB)
Immunohistochemistry (IHC)
Immunofluorescence (IF)
Immunocytochemistry (ICC)
Immunoprecipitation (IP)
Co-Immunoprecipitation (CoIP)
Chromatin Immunoprecipitation (ChIP)
RNA Binding Protein Immunoprecipitation (RIP)
Sample
Loading Amount
Loading Type
UG
CELLS
Treatment
Temperature
Exposure
Observe Band
Fixative
Select One
Acetone
Formaldehyde
Methanol
Paraformaldehyde
Other
Antigen Retrieval
Select One
Heat mediated
Enzymatic
Other
None
Positive Control
Negative Control
Dilution *
1:
Incubation Time *
Select Image *
Choose a file...
Rating *
Remarks *
Submit Review
Product Description
AG-490 is an tyrosine kinase inhibitor, inhibits
EGFR
and
Stat-3
.
IC50 & Target: EGFR and Stat-3
[1]
In Vitro:
AG490 inhibits the activation of Stat-3 by selectively blocking JAK2. AG490 is used to selectively inhibit JAK/Stat-3 activation. At a dose of 10 μM, Stat-3 phosphorylation is decreased by >95% and cell viability is maintained. AG490 at a dose of 10 μM results in >95% decrease in pStat-3 in EGF-stimulated A431 cells with no effect on Stat-3 mass
[1]
. AG-490 is a potent inhibitor of the JAK3/STAT, JAK3/AP-1, and JAK3/MAPK pathways and their cellular consequences. AG-490 abolishes IL-2-inducible [
3
H]thymidine incorporation in a dose-dependent manner, displaying an IC
50
of 25 μM. AG-490 potently inhibits IL-2-mediated proliferation in T cells, results distinct from previous studies that showed this agent induced apoptosis in ALL cells while exerting apparently no effects on the growth of mitogen-stimulated normal T cells
[2]
.
In Vivo:
AG490 significantly inhibits the development of type 1 diabetes (T1D) (p = 0.02, p = 0.005; at two different time points). Monotherapy of newly diagnosed diabetic NOD mice with AG490 (1 mg/mouse) markedly results in disease remission in treated animals (n=23) in comparision to the absolute inability (0%; 0/10, p=0.003, Log-rank test) of DMSO and sustained eugluycemia is maintained for several months following drug withdrawal
[3]
. AG490 (1-10 µg) significantly attenuates ʎ-carrageenan-induced thermal hyperalgesia in a dose-dependent manner. AG490 also reduces mechanical hyperalgesia
[4]
.
Information
CAS No
133550-30-8
Formula
C
17
H
14
N
2
O
3
Clinical Information
clinicalinformation
Pathway
JAK/STAT Signaling
Protein Tyrosine Kinase/RTK
Autophagy
JAK/STAT Signaling
Stem Cell/Wnt
Target
EGFR
EGFR
Autophagy
STAT
STAT
Specifications
Storage Buffer
5% DMSO+40% PEG300+5% Tween80+50% 6.25mg/ml
Purity / Grade
>98%
Solubility
DMSO 58.0 mg/mL (197.1 mM)
Ethanol 6.0 mg/mL (20.4 mM)
Water Insoluble
Smiles
smiles
Misc Information
Storage Instruction
Powder: -20°C for 3 years In Solvent: -80°C 12 months
Alternative Names
Tyrphostin AG 490
Observed Molecular Weight
294.3
Notes
Mechanism: AG-490 blocks protein tyrosine kinases by binding to the substrate-binding site.
related data
Get valuable resources and offers directly to your email.
REGISTER NOW